Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

VIVUS, INC.

(VVUSQ)
Cours en clôture. Cours en clôture Other OTC - 11/12
0.1174 USD   +1.56%
2018VIVUS, INC. : REVERSE SPLIT: 1 pour 10
FA
SynthèseGraphiquesActualitésNotationsSociétéFondsCommunauté 
SynthèseToute l'actualitéAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur VIVUS, INC.
2020VIVUS  : Receives Court Approval of Joint Chapter 11 Plan of Reorganization
2020VIVUS  : Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan..
2020VIVUS INC  : Other Events, Financial Statements and Exhibits (form 8-K)
2020VIVUS INC  : Notice of Delisting or Failure to Satisfy a Continued Listing Rule ..
2020Health Care Flat As Growth Investors Seek Out Tech -- Health Care Roundup
2020VIVUS INC  : Entry into a Material Definitive Agreement, Bankruptcy or Receivers..
2020VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Who..
2020VIVUS INC  : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
2020VIVUS INC  : Entry into a Material Definitive Agreement, Regulation FD Disclosur..
2020VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.
2020VIVUS INC  : Results of Operations and Financial Condition, Financial Statements..
2020VIVUS : 1Q Earnings Snapshot
2020VIVUS INC  : Results of Operations and Financial Condition, Financial Statements..
2020VIVUS  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
2020VIVUS Reports First Quarter 2020 Financial Results
2020VIVUS  : Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Da..
2020VIVUS  : to Host First Quarter Business Update and Financial Results Conference ..
2020VIVUS to Host First Quarter Business Update and Financial Results Conference ..
2020VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Da..
2020VIVUS INC  : Entry into a Material Definitive Agreement, Triggering Events That ..
2020VIVUS INC  : Other Events, Financial Statements and Exhibits (form 8-K)
2020VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced A..
2020VITALTECH  : Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehea..
2020VIVUS INC  : Entry into a Material Definitive Agreement, Other Events, Financial..
2020VIVUS  : Announces $11.55 Million Registered Direct Offering Priced At-the-Marke..
2020VIVUS  : Accelerates the Launch of Telemedicine and Remote Monitoring Modules to..
2020VIVUS INC  : Other Events, Financial Statements and Exhibits (form 8-K)
2020VIVUS Accelerates the Launch of Telemedicine and Remote Monitoring Modules to..
2020VIVUS  : SEC Filing (CT ORDER) - Confidential Treatment Order
2020VIVUS INC  : Entry into a Material Definitive Agreement, Financial Statements an..
2020VIVUS INC  : Results of Operations and Financial Condition, Financial Statements..
2020VIVUS : 4Q Earnings Snapshot
2020VIVUS INC  : Results of Operations and Financial Condition, Financial Statements..
2020VIVUS Reports Fourth Quarter and Full Year 2019 Financial Results
2020VIVUS  : Management's Discussion and Analysis of Financial Condition and Results..
2020VIVUS  : Completes Enrollment in Phase 4 Safety and Efficacy Study of Qsymia in ..
2020VIVUS INC  : Other Events, Financial Statements and Exhibits (form 8-K)
2020VIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of Qsymia® in..
2020VIVUS INC  : Change in Directors or Principal Officers (form 8-K)
2020VIVUS  : Announces Commercial Launch of Qsymia in the Republic of Korea Establis..
2020VIVUS INC  : Other Events, Financial Statements and Exhibits (form 8-K)
2020VIVUS Announces Commercial Launch of Qsymia® in the Republic of Korea Establi..
2020VIVUS to Host Fourth Quarter Business Update and Financial Results Conference..
2020VIVUS  : Receives U.S. Food and Drug Administration Approval for Improved Formul..
2020VIVUS INC  : Other Events, Financial Statements and Exhibits (form 8-K)
2020VIVUS Receives U.S. Food and Drug Administration Approval for Improved Formul..
2020VIVUS INC  : Change in Directors or Principal Officers (form 8-K)
2020VIVUS  : New Data Further Demonstrate Effectiveness of VIVUS Qsymia as a Weight ..
2020VIVUS INC  : Other Events, Financial Statements and Exhibits (form 8-K)
2020New Data Further Demonstrate Effectiveness of VIVUS' Qsymia as a Weight Manag..
2020VIVUS  : Adopts Stockholder Rights Plan
2020VIVUS to Present at Biotech Showcase on January 13, 2020
2019VIVUS INC  : Entry into a Material Definitive Agreement, Material Modification t..
2019VIVUS Adopts Stockholder Rights Plan
2019VIVUS  : Announces New Data Supporting the Safety and Efficacy of Qsymia in Adol..
2019VIVUS INC  : Other Events, Financial Statements and Exhibits (form 8-K)
2019VIVUS Announces New Data Supporting the Safety and Efficacy of Qsymia® in Ado..
2019VIVUS  : to Present at Piper Jaffray 31st Annual Healthcare Conference on Decemb..
2019VIVUS to Present at Piper Jaffray 31st Annual Healthcare Conference on Decem..
2019VIVUS  : New Clinical Data Demonstrate VIVUS Qsymia is Effective at Reducing Bin..
2019VIVUS INC  : Other Events, Financial Statements and Exhibits (form 8-K)
2019New Clinical Data Demonstrate VIVUS' Qsymia® is Effective at Reducing Binge E..
2019VIVUS Reports Third Quarter 2019 Financial Results
2019VIVUS Announces Departures of Eric W. Roberts and Allan L. Shaw from Board of..
2019VIVUS to Host Third Quarter Business Update and Financial Results Conference ..
2019VIVUS to Highlight Integrated Approach to More Effective Weight Management in..
2019VIVUS Announces Acceptance of Qsymia Decentralized Marketing Authorization Ap..
2019VIVUS Initiates Pay Down of Secured Debt and Announces Management Changes
2019VIVUS to Present at Upcoming Conferences
2019VIVUS to Share Qsymia® Safety and Efficacy Data with a Global Audience at ICO..
2019New Pilot Clinical Study Results Demonstrate that Addition of VIVUS' Qsymia® ..
2019VIVUS Announces Approval of Qsymia® in the Republic of Korea
2019VIVUS and Nordmark Amend Contract Manufacturing Agreement to Supply Current a..
2019VIVUS Reduces Barrier to Achieving Healthy Weight Goals With Launch of Online..
2019VIVUS Reports First Quarter 2019 Financial Results
1  2Suiv.